Conditions: Advanced Solid Tumor
Interventions: Biological: BNT317 DL1; Biological: BNT317 DL2; Biological: BNT317 DL3; Biological: BNT317 DL4; Biological: BNT317 DL5; Biological: BNT317 DL6; Biological: BNT317 selected DLA; Biological: BNT317 selected DLB; Drug: SoC chemotherapy 1; Drug: SoC chemotherapy 2
Sponsors: BioNTech SE
**RECRUITING NOW**
Interventions: Biological: BNT317 DL1; Biological: BNT317 DL2; Biological: BNT317 DL3; Biological: BNT317 DL4; Biological: BNT317 DL5; Biological: BNT317 DL6; Biological: BNT317 selected DLA; Biological: BNT317 selected DLB; Drug: SoC chemotherapy 1; Drug: SoC chemotherapy 2
Sponsors: BioNTech SE
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
